Kulevich E E, Sedel'nikova O A, Petrovichev N N, Chistiakova O V
Arkh Patol. 1993 Mar-Apr;55(2):6-8.
Monoclonal antibodies (MAB) were obtained against the antigens isolated from the fraction of external plasmatic membranes of human breast cancer (RMZh-I). 170 epithelial and non-epithelial primary and metastatic human tumours of various localization were studied by an immunoperoxidase method using the above antibodies. Positive reactivity with RMZh-I was observed in the epithelial tumors of mammary gland, uterus, ovaries, thyroid, lung, gastrointestinal tract, kidney. Mab did not react with hematopoietic and sarcomatous tumours. The parameters of the immunoperoxidase reaction were identical at both histologic and cytologic levels. MAB RMZh-I may be used as an epithelial marker for differential diagnosis of carcinoma metastases and lymphoproliferative disease.
获得了针对从人乳腺癌外质膜部分(RMZh-I)分离的抗原的单克隆抗体(MAB)。使用上述抗体通过免疫过氧化物酶法研究了170例不同部位的人原发性和转移性上皮性及非上皮性肿瘤。在乳腺、子宫、卵巢、甲状腺、肺、胃肠道、肾脏的上皮性肿瘤中观察到与RMZh-I的阳性反应。Mab与造血系统肿瘤和肉瘤不发生反应。免疫过氧化物酶反应的参数在组织学和细胞学水平上是相同的。MAB RMZh-I可作为上皮标志物用于癌转移和淋巴增殖性疾病的鉴别诊断。